Medical Technology Disruptor

We Are Medivolve

We seek out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors.
We are a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space

We trust and know what we do today will impact hundreds of generations of tomorrow.

Medivolve (NEO:QSC; OTC:COPRF; FRA:34C1) is a Canadian publicly-traded company.

Medivolve's wholly-owned subsidiary Collection Sites, LLC continues to help consumers access its effective and convenient COVID-19 testing solution

Collection Sites is rolling out a network of mobile COVID-19 testing centres across the United States to ensure people get tested in a safe and efficient manner.

What We Do

Our team is built to search for challenges, develop solutions, and solve the crisis at hand through strategic investment of human and financial resources.

Our Proprietary Advantage

Actionable Intelligence

  • Research team Google Partner powered digital analytics

  • Investment team with combined experience of 500-years +

  • Advisory board providing wide spectrum of brilliant insight

  • Network comprised of experts, specialists & thought leaders

  • Global team of operational teams and organizations

Investment Philosophy

Speed Obsessed

Medivolve invests resources in developing and delivering solutions to challenges that requires velocity without compromise

Betterment Focused

Medivolve measures and monitors the return on investment to ensure metrics of betterment are achieved as the first investment-priority

Positive Performance

Medivolve mandates that following a purposeful return on investment bandwidth and focus is equally a positive return on investment of resources

Join Medivolve's Investor Mailing List Today

Stay up to date on the latest developments and breakthroughs.

In accordance with Canada’s anti-spam legislation, by sending us your email address and other personal information you consent to receiving communications from us related to our business, operations and certain investment opportunities, but only to the extent that you qualify to participate in any such opportunities. You also consent to us sharing your personal information with third-party marketing companies strictly for the purposes set out above. You may revoke your consent at any time by emailing us at You further confirm that you are not a resident of any country in the European Economic Area.